Medtronic Research Development from 2010 to 2026
| MDT Stock | USD 102.96 1.96 1.94% |
Research Development | First Reported 1993-07-31 | Previous Quarter 726 M | Current Value 754 M | Quarterly Volatility 217 M |
Check Medtronic PLC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medtronic PLC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.5 B, Interest Expense of 880.3 M or Total Revenue of 40.5 B, as well as many indicators such as Price To Sales Ratio of 5.24, Dividend Yield of 0.0311 or PTB Ratio of 2.48. Medtronic financial statements analysis is a perfect complement when working with Medtronic PLC Valuation or Volatility modules.
Medtronic | Research Development | Build AI portfolio with Medtronic Stock |
The evolution of Research Development for Medtronic PLC provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Medtronic PLC compares to historical norms and industry peers.
Latest Medtronic PLC's Research Development Growth Pattern
Below is the plot of the Research Development of Medtronic PLC over the last few years. It is Medtronic PLC's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medtronic PLC's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Medtronic Research Development Regression Statistics
| Arithmetic Mean | 2,205,705,294 | |
| Geometric Mean | 1,935,424,505 | |
| Coefficient Of Variation | 34.49 | |
| Mean Deviation | 555,403,737 | |
| Median | 2,330,000,000 | |
| Standard Deviation | 760,823,271 | |
| Sample Variance | 578852.1T | |
| Range | 3.1B | |
| R-Value | 0.92 | |
| Mean Square Error | 95679.1T | |
| R-Squared | 0.85 | |
| Slope | 138,500,784 | |
| Total Sum of Squares | 9261632.8T |
Medtronic Research Development History
About Medtronic PLC Financial Statements
Medtronic PLC shareholders use historical fundamental indicators, such as Research Development, to determine how well the company is positioned to perform in the future. Although Medtronic PLC investors may analyze each financial statement separately, they are all interrelated. The changes in Medtronic PLC's assets and liabilities, for example, are also reflected in the revenues and expenses on on Medtronic PLC's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 3.1 B | 3.3 B |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.